PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation

Alessi, 1997, 3-phosphoinositide-dependent protein kinase-1 (PDK-1): structural and functional homology with the Drosophila DSTPK61 kinase, Curr. Biol., 7, 776, 10.1016/S0960-9822(06)00336-8 Anton, 1995, Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression, J. Virol., 69, 4600, 10.1128/JVI.69.8.4600-4606.1995 Cheney, 1998, Suppresion of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer, Cancer Res., 58, 2331 Clayman, 1995, In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma, Cancer Res., 55, 1 Cole, 1986, The c-myc oncogene: Its role in transformation and differentiation, Annu. Rev. Genet., 20, 361, 10.1146/annurev.ge.20.120186.002045 Davies, 1998, Adenoviral transgene expression of MMAC1/PTEN in human glioma cells inhibits Akt activation and induces anoikis, Cancer Res., 58, 5285 Devilee, 1994, Recent development in the molecular genetic understanding of breast cancer, Crit. Rev. Oncog., 5, 247, 10.1615/CritRevOncog.v5.i2-3.70 Downward, 1998, Mechanisms and consequences of activation of protein kinase B/Akt, Curr. Opin. Cell Biol., 10, 262, 10.1016/S0955-0674(98)80149-X Dubik, 1987, Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells, Cancer Res., 47, 6517 Dubik, 1988, Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells, J. Biol. Chem., 263, 12705, 10.1016/S0021-9258(18)37810-4 Furnari, 1997, Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain, Proc. Natl. Acad. Sci. USA, 94, 12479, 10.1073/pnas.94.23.12479 Hamburger, 1980, Development of a bioassay for human myeloma colony-forming cells, Prog. Clin. Biol. Res., 48, 23 He, 1998, A simplified system for generating recombinant adenovirus, Proc. Natl. Acad. Sci. USA, 95, 2509, 10.1073/pnas.95.5.2509 Kauffman-Zeh, 1997, Suppression of c-myc-induced apoptosis by Ras signaling through PI(3)K and PKB, Nature, 385, 544, 10.1038/385544a0 Lasko, 1991, Loss of constitutional heterozygosity in human cancer, Annu. Rev. Genet., 25, 281, 10.1146/annurev.ge.25.120191.001433 Levy, 1993, Complementation by wild-typr p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression, Mol. Cell. Biol., 13, 7942, 10.1128/MCB.13.12.7942 Li, 1997, TEPI, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β, Cancer Res., 57, 2124 Li, 1997, PTEN, a putative protein tyrosine phosphate gene muluted in human brain, breast and prostate cancer, Science, 275, 1943, 10.1126/science.275.5308.1943 Li, 1998, The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by AKT/Protein Kinase B oncogene, Cancer Res., 58, 5667 Liaw, 1997, Germline mutations of the PTEN gene in Cowden disease, an inheritied breast and thyroid cancer syndrome, Nat. Genet., 16, 64, 10.1038/ng0597-64 Maehama, 1998, The tumor suppressor, PTEN/MMACI, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate, J. Biol. Chem., 273, 13375, 10.1074/jbc.273.22.13375 March, 1997, Germline mutations in PTEN are present in Bannayan–Zonana syndrome, Nat. Genet., 16, 333, 10.1038/ng0897-333 Morgan, 1993, Human gene therapy, Annu. Rev. Biochem., 62, 191, 10.1146/annurev.bi.62.070193.001203 Myers, 1997, P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase, Proc. Natl. Acad. Sci. USA, 94, 9052, 10.1073/pnas.94.17.9052 Pavelic, 1991, Evaluation of c-myc protooncogene in primary human breast carcinomas, Anticancer Res., 11, 1421 Ray, 1991, Cloning and characterization of a human c-myc promotor-binding protein, Mol. Cell. Biol., 11, 2154, 10.1128/MCB.11.4.2154 Ray, 1995, Induction of cell death in murine fibroblasts by a c-myc promoter binding protein, Cell Growth Differ., 6, 1089 Ray, 1995, Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice, Cancer Res., 55, 3747 Schoenenberger, 1988, Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumors with constitutive milk protein gene transcription, EMBO J., 7, 169, 10.1002/j.1460-2075.1988.tb02797.x Spandidos, 1989, High levels of c-myc protein in human breast tumors determined by a sensitive ELISA technique, Anticancer Res., 9, 821 Spencer, 1991, Control of c-myc regulation in normal and neoplastic cells, Adv. Cancer Res., 53, 1, 10.1016/S0065-230X(08)60476-5 Steck, 1997, Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers, Nat. Genet., 15, 356, 10.1038/ng0497-356 Stokoe, 1997, Dual role of phosphatidylinositol-3,4,5-triphosphate in the activation of protein kinase B, Science, 277, 567, 10.1126/science.277.5325.567 Tamura, 1998, Inhibition of cell migration, spreading, and focal adgesions by tumor suppressor PTEN, Science, 280, 1614, 10.1126/science.280.5369.1614 Wingo, 1995, Cancer statistics Ca:a, Cancer J. Clin., 45, 8, 10.3322/canjclin.45.1.8